Abstract

Arginine vasopressin (AVP) plays a major role in the homeostasis of fluid balance, vascular tonus, and the regulation of the endocrine stress response. The measurement of AVP levels is difficult due to its short half-life and laborious method of detection. Copeptin is a more stable peptide derived from the same precursor molecule, is released in an equimolar ratio to AVP, and has a very similar response to osmotic, hemodynamic, and stress-related stimuli. In fact, copeptin has been propagated as surrogate marker to indirectly determine circulating AVP concentrations in various conditions. Here, we present an overview of the current knowledge on AVP and copeptin in perinatology with a particular focus on the baby’s transition from placenta to lung breathing. We performed a systematic review of the literature on fetal stress hormone levels, including norepinephrine, cortisol, AVP, and copeptin, in regard to birth stress. Finally, diagnostic and therapeutic options for copeptin measurement and AVP functions are discussed.

Highlights

  • The nature of stress hormones is comparable to that of firefighters: they act fast on demand and pull back as soon as possible

  • V1b receptors are primarily located on specialized cells, called corticotrophs, in the anterior pituitary gland, where they stimulate the release of adrenocorticotropic hormone (ACTH) synergistically with corticotropinreleasing hormone (CRH)

  • The great advantages of copeptin measurement are the remarkably high sensitivity of this robust Arginine vasopressin (AVP) surrogate marker, its extreme stability once collected in blood sampling tubes, and the fact that only 50 μl of serum or plasma are needed for the assay [9]

Read more

Summary

Katrina Suzanne Evers and Sven Wellmann*

Division of Neonatology, University of Basel Children’s Hospital (UKBB), Basel, Switzerland. Arginine vasopressin (AVP) plays a major role in the homeostasis of fluid balance, vascular tonus, and the regulation of the endocrine stress response. The measurement of AVP levels is difficult due to its short half-life and laborious method of detection. Copeptin is a more stable peptide derived from the same precursor molecule, is released in an equimolar ratio to AVP, and has a very similar response to osmotic, hemodynamic, and stress-related stimuli. We present an overview of the current knowledge on AVP and copeptin in perinatology with a particular focus on the baby’s transition from placenta to lung breathing. We performed a systematic review of the literature on fetal stress hormone levels, including norepinephrine, cortisol, AVP, and copeptin, in regard to birth stress.

INTRODUCTION
PRODUCTION OF AVP AND COPEPTIN
AVP RECEPTORS
AVP AND COPEPTIN MEASUREMENT
SURGE IN FETAL STRESS HORMONES
LABOR AND AVP AND COPEPTIN RELEASE
AVP IN HEALTHY NEONATES
Body Fluid Homeostasis
Cardiovascular System
Sex Difference
AVP IN NEWBORN DISEASES
AVP IN THERAPY
CONCLUSION
Findings
AUTHOR CONTRIBUTIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.